3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
5
Stomach Neoplasms
3
Carcinoma, Renal Cell
3
Uterine Cervical Neoplasms
2
Triple Negative Breast Neoplasms
2
Lung Neoplasms
2
Kidney Neoplasms
2
Adenocarcinoma Of Esophagus
2
Urothelial Bladder Carcinoma
1
Urinary Bladder Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumors
1
Recurrence
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Metastatic Urothelial Cancer
1
Melanoma
1
Lung Diseases
1
Glioblastoma
1
Esophageal Neoplasms
1
Erythrocytosis, Familial, 4
1
Carcinoma, Transitional Cell
1
Advanced Solid Tumors
1
Interventions
Specimen Handling
4
Doxorubicin
4
pembrolizumab
3
Radiotherapy
3
Radiation
3
Magnetic Resonance Spectroscopy
3
Biopsy
3
pazopanib
2
palbociclib
2
Immunoglobulin G
2
Ifosfamide
2
toripalimab
1
talimogene laherparepvec
1
silmitasertib
1
selinexor
1
ribociclib
1
peposertib
1
mirdametinib
1
liposomal doxorubicin
1
eribulin
1
durvalumab
1
cemiplimab
1
abemaciclib
1
X-Rays
1
Vincristine
1
Temozolomide
1
Surgical Procedures, Operative
1
Radiotherapy, Intensity-Modulated
1
Proton Therapy
1
Nivolumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Liposarcoma
×
zimberelimab
×
90 days
×
Clear all
No trials found.